New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1

Tyrosyl-DNA phosphodiesterase 1 (TDP1) catalyzes the cleavage of the phosphodiester bond between the tyrosine residue of topoisomerase 1 (TOP1) and the 3′ phosphate of DNA in the single-strand break generated by TOP1. TDP1 promotes the cleavage of the stable DNA–TOP1 complexes with the TOP1 inhibito...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nadezhda S. Dyrkheeva, Aleksandr S. Filimonov, Olga A. Luzina, Kristina A. Orlova, Irina A. Chernyshova, Tatyana E. Kornienko, Anastasia A. Malakhova, Sergey P. Medvedev, Alexandra L. Zakharenko, Ekaterina S. Ilina, Rashid O. Anarbaev, Konstantin N. Naumenko, Kristina V. Klabenkova, Ekaterina A. Burakova, Dmitry A. Stetsenko, Suren M. Zakian, Nariman F. Salakhutdinov, Olga I. Lavrik
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/ffbea489293848d98465c39d785114bf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ffbea489293848d98465c39d785114bf
record_format dspace
spelling oai:doaj.org-article:ffbea489293848d98465c39d785114bf2021-11-11T16:49:04ZNew Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP110.3390/ijms2221113361422-00671661-6596https://doaj.org/article/ffbea489293848d98465c39d785114bf2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11336https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Tyrosyl-DNA phosphodiesterase 1 (TDP1) catalyzes the cleavage of the phosphodiester bond between the tyrosine residue of topoisomerase 1 (TOP1) and the 3′ phosphate of DNA in the single-strand break generated by TOP1. TDP1 promotes the cleavage of the stable DNA–TOP1 complexes with the TOP1 inhibitor topotecan, which is a clinically used anticancer drug. This article reports the synthesis and study of usnic acid thioether and sulfoxide derivatives that efficiently suppress TDP1 activity, with IC<sub>50</sub> values in the 1.4–25.2 μM range. The structure of the heterocyclic substituent introduced into the dibenzofuran core affects the TDP1 inhibitory efficiency of the compounds. A five-membered heterocyclic fragment was shown to be most pharmacophoric among the others. Sulfoxide derivatives were less cytotoxic than their thioester analogs. We observed an uncompetitive type of inhibition for the four most effective inhibitors of TDP1. The anticancer effect of TOP1 inhibitors can be enhanced by the simultaneous inhibition of PARP1, TDP1, and TDP2. Some of the compounds inhibited not only TDP1 but also TDP2 and/or PARP1, but at significantly higher concentration ranges than TDP1. Leader compound <b>10a</b> showed promising synergy on HeLa cells in conjunction with the TOP1 inhibitor topotecan.Nadezhda S. DyrkheevaAleksandr S. FilimonovOlga A. LuzinaKristina A. OrlovaIrina A. ChernyshovaTatyana E. KornienkoAnastasia A. MalakhovaSergey P. MedvedevAlexandra L. ZakharenkoEkaterina S. IlinaRashid O. AnarbaevKonstantin N. NaumenkoKristina V. KlabenkovaEkaterina A. BurakovaDmitry A. StetsenkoSuren M. ZakianNariman F. SalakhutdinovOlga I. LavrikMDPI AGarticleusnic acidthioethertyrosyl-DNA phosphodiesterase 1TDP1 inhibitorinhibiting activityTDP2Biology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11336, p 11336 (2021)
institution DOAJ
collection DOAJ
language EN
topic usnic acid
thioether
tyrosyl-DNA phosphodiesterase 1
TDP1 inhibitor
inhibiting activity
TDP2
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle usnic acid
thioether
tyrosyl-DNA phosphodiesterase 1
TDP1 inhibitor
inhibiting activity
TDP2
Biology (General)
QH301-705.5
Chemistry
QD1-999
Nadezhda S. Dyrkheeva
Aleksandr S. Filimonov
Olga A. Luzina
Kristina A. Orlova
Irina A. Chernyshova
Tatyana E. Kornienko
Anastasia A. Malakhova
Sergey P. Medvedev
Alexandra L. Zakharenko
Ekaterina S. Ilina
Rashid O. Anarbaev
Konstantin N. Naumenko
Kristina V. Klabenkova
Ekaterina A. Burakova
Dmitry A. Stetsenko
Suren M. Zakian
Nariman F. Salakhutdinov
Olga I. Lavrik
New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
description Tyrosyl-DNA phosphodiesterase 1 (TDP1) catalyzes the cleavage of the phosphodiester bond between the tyrosine residue of topoisomerase 1 (TOP1) and the 3′ phosphate of DNA in the single-strand break generated by TOP1. TDP1 promotes the cleavage of the stable DNA–TOP1 complexes with the TOP1 inhibitor topotecan, which is a clinically used anticancer drug. This article reports the synthesis and study of usnic acid thioether and sulfoxide derivatives that efficiently suppress TDP1 activity, with IC<sub>50</sub> values in the 1.4–25.2 μM range. The structure of the heterocyclic substituent introduced into the dibenzofuran core affects the TDP1 inhibitory efficiency of the compounds. A five-membered heterocyclic fragment was shown to be most pharmacophoric among the others. Sulfoxide derivatives were less cytotoxic than their thioester analogs. We observed an uncompetitive type of inhibition for the four most effective inhibitors of TDP1. The anticancer effect of TOP1 inhibitors can be enhanced by the simultaneous inhibition of PARP1, TDP1, and TDP2. Some of the compounds inhibited not only TDP1 but also TDP2 and/or PARP1, but at significantly higher concentration ranges than TDP1. Leader compound <b>10a</b> showed promising synergy on HeLa cells in conjunction with the TOP1 inhibitor topotecan.
format article
author Nadezhda S. Dyrkheeva
Aleksandr S. Filimonov
Olga A. Luzina
Kristina A. Orlova
Irina A. Chernyshova
Tatyana E. Kornienko
Anastasia A. Malakhova
Sergey P. Medvedev
Alexandra L. Zakharenko
Ekaterina S. Ilina
Rashid O. Anarbaev
Konstantin N. Naumenko
Kristina V. Klabenkova
Ekaterina A. Burakova
Dmitry A. Stetsenko
Suren M. Zakian
Nariman F. Salakhutdinov
Olga I. Lavrik
author_facet Nadezhda S. Dyrkheeva
Aleksandr S. Filimonov
Olga A. Luzina
Kristina A. Orlova
Irina A. Chernyshova
Tatyana E. Kornienko
Anastasia A. Malakhova
Sergey P. Medvedev
Alexandra L. Zakharenko
Ekaterina S. Ilina
Rashid O. Anarbaev
Konstantin N. Naumenko
Kristina V. Klabenkova
Ekaterina A. Burakova
Dmitry A. Stetsenko
Suren M. Zakian
Nariman F. Salakhutdinov
Olga I. Lavrik
author_sort Nadezhda S. Dyrkheeva
title New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
title_short New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
title_full New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
title_fullStr New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
title_full_unstemmed New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
title_sort new hybrid compounds combining fragments of usnic acid and thioether are inhibitors of human enzymes tdp1, tdp2 and parp1
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ffbea489293848d98465c39d785114bf
work_keys_str_mv AT nadezhdasdyrkheeva newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT aleksandrsfilimonov newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT olgaaluzina newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT kristinaaorlova newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT irinaachernyshova newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT tatyanaekornienko newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT anastasiaamalakhova newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT sergeypmedvedev newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT alexandralzakharenko newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT ekaterinasilina newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT rashidoanarbaev newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT konstantinnnaumenko newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT kristinavklabenkova newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT ekaterinaaburakova newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT dmitryastetsenko newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT surenmzakian newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT narimanfsalakhutdinov newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
AT olgailavrik newhybridcompoundscombiningfragmentsofusnicacidandthioetherareinhibitorsofhumanenzymestdp1tdp2andparp1
_version_ 1718432277628715008